SMTL ID : 4lmn.1 (1 other biounit)

Crystal Structure of MEK1 kinase bound to GDC0973

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

monomer

Ligands

1 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)

ANP.1: 23 residues within 4Å: Chain A: L.14, G.15, A.16, G.17, N.18, G.20, V.22, A.35, K.37, M.83, E.84, H.85, M.86, S.90, Q.93, D.130, K.132, S.134, N.135, L.137, D.148 Ligands: MG.2, EUI.3 10 PLIP interactions: 10 interactions with chain A Hydrogen bonds: A:G.17, A:E.84, A:M.86, A:S.90, A:S.90, A:K.132, A:S.134, A:S.134, A:N.135 Salt bridges: A:K.37

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 4 residues within 4Å: Chain A: S.134, N.135, D.148 Ligands: ANP.1 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:D.148

1 x EUI: [3,4-BIS(FLUORANYL)-2-[(2-FLUORANYL-4-IODANYL-PHENYL)AMINO]PHENYL]-[3-OXIDANYL-3-[(2S)-PIPERIDIN-2-YL]AZETIDIN-1-YL]METHANONE(Non-covalent)

EUI.3: 17 residues within 4Å: Chain A: K.37, L.55, L.58, V.67, I.81, M.83, D.130, N.135, D.148, F.149, G.150, V.151, S.152, L.155, M.159, N.161 Ligands: ANP.1 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.58, A:I.81, A:L.155 Hydrogen bonds: A:N.135, A:D.148 pi-Stacking: A:F.149 Halogen bonds: A:V.67

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hatzivassiliou, G. et al., Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers. Nature (2013)

Release Date

2013-08-07

Peptides

Dual specificity mitogen-activated protein kinase kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Dual specificity mitogen-activated protein kinase kinase 1

Related Entries With Identical Sequence